ESR1 and neoplasm: Previous reports have implicated that DACH1 could suppress tumor cell proliferation, migration, and invasion by mediating other important biomarkers, such as Estrogen Receptor-α, Peroxiredoxin 3, Wnt/β-catenin signaling Smad4, and TGF-β [5, 30–33].